Konstantinos Leventakos, MD, PhD, is a medical oncologist with a focus on thoracic malignancies, personalized medicine, and immunotherapy. His clinical focus includes, n
on-small cell lung cancer,
s
mall cell lung cancer, m
esothelioma, t
hymic malignancies, n
euroendocrine tumors, m
ultidisciplinary approach to thoracic malignancies and personalized medicine, and the i
ntegration of Artificial Intelligence (AI) for clinical trial matching.
In addition to his clinical activities, Dr. Leventakos is active in research and education of medical students, residents, and oncology fellows. He publishes in many journals and speaks at many national and international meetings.